Published in Arch Ophthalmol on September 01, 2010
Pilot Study to Evaluate Levodopa as Treatment for Residual Amblyopia (ATS14) | NCT00789672
A randomized trial of levodopa as treatment for residual amblyopia in older children. Ophthalmology (2015) 2.42
Occlusion for stimulus deprivation amblyopia. Cochrane Database Syst Rev (2014) 0.82
Levodopa as a possible treatment of visual loss in nonarteritic anterior ischemic optic neuropathy. Graefes Arch Clin Exp Ophthalmol (2015) 0.80
Does levodopa improve vision in albinism? Results of a randomized, controlled clinical trial. Clin Experiment Ophthalmol (2014) 0.75
Efficiency of the occlusion therapy with and without levodopa-carbidopa in amblyopic children-A tertiary care centre experience. Int J Health Sci (Qassim) (2016) 0.75
Occlusion-amblyopia following high dose oral levodopa combined with part time patching. Indian J Ophthalmol (2014) 0.75
Pharmacological therapy for amblyopia. Taiwan J Ophthalmol (2017) 0.75
Dopamine signaling and myopia development: What are the key challenges. Prog Retin Eye Res (2017) 0.75
A computerized method of visual acuity testing: adaptation of the early treatment of diabetic retinopathy study testing protocol. Am J Ophthalmol (2003) 9.99
Longitudinal study of levodopa/carbidopa for childhood amblyopia. J Pediatr Ophthalmol Strabismus (1994) 1.28
Visual acuities and scotomas after 3 weeks' levodopa administration in adult amblyopia. Graefes Arch Clin Exp Ophthalmol (1995) 1.21
Levodopa/carbidopa treatment for amblyopia in older children. J Pediatr Ophthalmol Strabismus (1995) 1.08
Long-term follow-up of L-dopa treatment in children with amblyopia. J Pediatr Ophthalmol Strabismus (2002) 1.08
Visual acuities after levodopa administration in amblyopia. J Pediatr Ophthalmol Strabismus (2001) 1.07
The effect of increasing doses of levodopa on children with strabismic amblyopia. J AAPOS (1999) 1.04
Occlusion and levodopa-carbidopa treatment for childhood amblyopia. J AAPOS (1998) 1.02
Levodopa-carbidopa with occlusion in older children with amblyopia. J AAPOS (2002) 0.96
Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med (2008) 17.19
Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology (2010) 10.28
A computerized method of visual acuity testing: adaptation of the early treatment of diabetic retinopathy study testing protocol. Am J Ophthalmol (2003) 9.99
Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. N Engl J Med (2015) 7.08
Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema. Ophthalmology (2006) 5.79
The amblyopia treatment study visual acuity testing protocol. Arch Ophthalmol (2001) 5.78
A randomized trial of patching regimens for treatment of moderate amblyopia in children. Arch Ophthalmol (2003) 5.27
The effect of continuous glucose monitoring in well-controlled type 1 diabetes. Diabetes Care (2009) 4.93
A randomized trial of prescribed patching regimens for treatment of severe amblyopia in children. Ophthalmology (2003) 4.88
Randomized trial of treatment of amblyopia in children aged 7 to 17 years. Arch Ophthalmol (2005) 4.38
Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology (2011) 4.15
A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema. Ophthalmology (2007) 3.49
A randomized trial of atropine regimens for treatment of moderate amblyopia in children. Ophthalmology (2004) 3.48
Two-year follow-up of a 6-month randomized trial of atropine vs patching for treatment of moderate amblyopia in children. Arch Ophthalmol (2005) 3.42
Comparison of the modified Early Treatment Diabetic Retinopathy Study and mild macular grid laser photocoagulation strategies for diabetic macular edema. Arch Ophthalmol (2007) 3.18
The accuracy of the FreeStyle Navigator continuous glucose monitoring system in children with type 1 diabetes. Diabetes Care (2007) 3.11
Continuous glucose monitoring in children with type 1 diabetes. J Pediatr (2007) 3.06
Panretinal photocoagulation for proliferative diabetic retinopathy. N Engl J Med (2011) 2.98
Treatment of anisometropic amblyopia in children with refractive correction. Ophthalmology (2006) 2.89
Prevalence of amblyopia and strabismus in white and African American children aged 6 through 71 months the Baltimore Pediatric Eye Disease Study. Ophthalmology (2009) 2.85
Factors predictive of use and of benefit from continuous glucose monitoring in type 1 diabetes. Diabetes Care (2009) 2.85
Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the Ambulatory Glucose Profile (AGP). Diabetes Technol Ther (2013) 2.85
Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema. Arch Ophthalmol (2009) 2.84
Impact of exercise on overnight glycemic control in children with type 1 diabetes mellitus. J Pediatr (2005) 2.83
Most youth with type 1 diabetes in the T1D Exchange Clinic Registry do not meet American Diabetes Association or International Society for Pediatric and Adolescent Diabetes clinical guidelines. Diabetes Care (2013) 2.73
Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: three-year randomized trial results. Ophthalmology (2012) 2.68
Comparison of fingerstick hemoglobin A1c levels assayed by DCA 2000 with the DCCT/EDIC central laboratory assay: results of a Diabetes Research in Children Network (DirecNet) Study. Pediatr Diabetes (2005) 2.64
Reproducibility of macular thickness and volume using Zeiss optical coherence tomography in patients with diabetic macular edema. Ophthalmology (2007) 2.58
A randomized trial to evaluate 2 hours of daily patching for strabismic and anisometropic amblyopia in children. Ophthalmology (2006) 2.51
A randomized trial of levodopa as treatment for residual amblyopia in older children. Ophthalmology (2015) 2.42
Retinal nerve fiber layer thickness in amblyopic eyes. Am J Ophthalmol (2009) 2.29
Prevalence of refractive error among preschool children in an urban population: the Baltimore Pediatric Eye Disease Study. Ophthalmology (2009) 2.27
A randomized trial of atropine vs patching for treatment of moderate amblyopia: follow-up at age 10 years. Arch Ophthalmol (2008) 2.26
The effect of donor age on corneal transplantation outcome results of the cornea donor study. Ophthalmology (2008) 2.19
Intravitreal bevacizumab as adjunctive treatment for retinopathy of prematurity. J AAPOS (2010) 2.11
The accuracy of the plusoptiX A08 photoscreener in detecting risk factors for amblyopia in central Iowa. J AAPOS (2013) 2.05
Treatment of symptomatic convergence insufficiency with a home-based computer orthoptic exercise program. J AAPOS (2011) 2.04
Evidence of a strong association between frequency of self-monitoring of blood glucose and hemoglobin A1c levels in T1D exchange clinic registry participants. Diabetes Care (2013) 2.03
Prevention of hypoglycemia during exercise in children with type 1 diabetes by suspending basal insulin. Diabetes Care (2006) 2.02
The clinical profile of moderate amblyopia in children younger than 7 years. Arch Ophthalmol (2002) 1.99
Lessons from the amblyopia treatment studies. Ophthalmology (2012) 1.99
The effects of aerobic exercise on glucose and counterregulatory hormone concentrations in children with type 1 diabetes. Diabetes Care (2006) 1.95
Donor age and corneal endothelial cell loss 5 years after successful corneal transplantation. Specular microscopy ancillary study results. Ophthalmology (2008) 1.94
Severe hypoglycemia and diabetic ketoacidosis in adults with type 1 diabetes: results from the T1D Exchange clinic registry. J Clin Endocrinol Metab (2013) 1.92
Treatment of severe amblyopia with weekend atropine: results from 2 randomized clinical trials. J AAPOS (2009) 1.89
Retinal thickness on Stratus optical coherence tomography in people with diabetes and minimal or no diabetic retinopathy. Am J Ophthalmol (2008) 1.87
Patching vs atropine to treat amblyopia in children aged 7 to 12 years: a randomized trial. Arch Ophthalmol (2008) 1.80
A randomized trial of near versus distance activities while patching for amblyopia in children aged 3 to less than 7 years. Ophthalmology (2008) 1.79
Resolution of congenital nasolacrimal duct obstruction with nonsurgical management. Arch Ophthalmol (2012) 1.79
Neuroanatomical correlates of dysglycemia in young children with type 1 diabetes. Diabetes (2013) 1.78
Clinical profile and early surgical complications in the Cornea Donor Study. Cornea (2006) 1.77
Retinopathy of prematurity outcome in infants with prethreshold retinopathy of prematurity and oxygen saturation >94% in room air: the high oxygen percentage in retinopathy of prematurity study. Pediatrics (2002) 1.77
Reliability of the electronic early treatment diabetic retinopathy study testing protocol in children 7 to <13 years old. Am J Ophthalmol (2003) 1.76
Accuracy of newer-generation home blood glucose meters in a Diabetes Research in Children Network (DirecNet) inpatient exercise study. Diabetes Technol Ther (2005) 1.75
Limitations of statistical measures of error in assessing the accuracy of continuous glucose sensors. Diabetes Technol Ther (2005) 1.74
Primary treatment of nasolacrimal duct obstruction with probing in children younger than 4 years. Ophthalmology (2007) 1.73
Observational study of the development of diabetic macular edema following panretinal (scatter) photocoagulation given in 1 or 4 sittings. Arch Ophthalmol (2009) 1.72
Risk factors associated with childhood strabismus: the multi-ethnic pediatric eye disease and Baltimore pediatric eye disease studies. Ophthalmology (2011) 1.70
Atropine vs patching for treatment of moderate amblyopia: follow-up at 15 years of age of a randomized clinical trial. JAMA Ophthalmol (2014) 1.70